Biggest News Aggregation in the World
📰 Case About News

Page 34 - Case About News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Case About. Real-time updates on events, politics, business and more.

Seagate Technology Holdings PLC (STX) Class Action Notice: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against Seagate Technology Holdings PLC

Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Seagate Technology Holdings PLC securities between...
Aaron Dumas Jr Us Export Administration Regulations Seagate Technology Holdings Huawei Technologies Co Us Department Of Commerce Aaron Dumas

BioXcel Therapeutics, Inc. (BTAI) Class Action Notice: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against BioXcel Therapeutics, Inc.

18.07.2023 - Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired BioXcel Therapeutics, Inc. (NASDAQ: BTAI) securities between December 15, 2021 and June 28, 2023. ...
Bioxcel Therapeutics Inc Case About Bioxcel Therapeutics Clinical Trial Failed Data Integrity Controls Institutional Review Board

BioXcel Therapeutics, Inc. (BTAI) Class Action Notice: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against BioXcel Therapeutics, Inc.

Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired BioXcel Therapeutics, Inc. securities between...
Aaron Dumas Jr Bioxcel Therapeutics Inc Bioxcel Therapeutics Aaron Dumas Case About Clinical Trial Failed

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

BioXcel Therapeutics, Inc. (BTAI) Investor Alert: Robbins LLP Reminds Investors of Class Action Against BioXcel Therapeutics, Inc. - BioXcel Therapeutics (NASDAQ:BTAI)

SAN DIEGO, July 13, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired BioXcel Therapeutics, Inc.
Aaron Dumas Jr Bioxcel Therapeutics Inc Bioxcel Therapeutics Aaron Dumas Case About Clinical Trial Failed

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science